The Annals of Pharmacotherapy
Title | The Annals of Pharmacotherapy PDF eBook |
Author | |
Publisher | |
Pages | 728 |
Release | 1996 |
Genre | |
ISBN |
DICP
Title | DICP PDF eBook |
Author | |
Publisher | |
Pages | |
Release | 1968 |
Genre | Drugs |
ISBN |
The Annals of Pharmacotherapy
Title | The Annals of Pharmacotherapy PDF eBook |
Author | |
Publisher | |
Pages | 658 |
Release | 1997 |
Genre | |
ISBN |
Pediatric Pharmacotherapy
Title | Pediatric Pharmacotherapy PDF eBook |
Author | Sandra Benavides |
Publisher | |
Pages | 909 |
Release | 2012 |
Genre | Medical |
ISBN | 9781932658897 |
Pharmacometrics
Title | Pharmacometrics PDF eBook |
Author | Ene I. Ette |
Publisher | John Wiley & Sons |
Pages | 1236 |
Release | 2013-03-14 |
Genre | Medical |
ISBN | 1118679512 |
Pharmacometrics is the science of interpreting and describing pharmacology in a quantitative fashion. The pharmaceutical industry is integrating pharmacometrics into its drug development program, but there is a lack of and need for experienced pharmacometricians since fewer and fewer academic programs exist to train them. Pharmacometrics: The Science of Quantitative Pharmacology lays out the science of pharmacometrics and its application to drug development, evaluation, and patient pharmacotherapy, providing a comprehensive set of tools for the training and development of pharmacometricians. Edited and written by key leaders in the field, this flagship text on pharmacometrics: Integrates theory and practice to let the reader apply principles and concepts. Provides a comprehensive set of tools for training and developing expertise in the pharmacometric field. Is unique in including computer code information with the examples. This volume is an invaluable resource for all pharmacometricians, statisticians, teachers, graduate and undergraduate students in academia, industry, and regulatory agencies.
Medications for Opioid Use Disorder Save Lives
Title | Medications for Opioid Use Disorder Save Lives PDF eBook |
Author | National Academies of Sciences, Engineering, and Medicine |
Publisher | National Academies Press |
Pages | 175 |
Release | 2019-06-16 |
Genre | Medical |
ISBN | 0309486483 |
The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.
Essential Evidence-Based Psychopharmacology
Title | Essential Evidence-Based Psychopharmacology PDF eBook |
Author | Dan Stein |
Publisher | Cambridge University Press |
Pages | 335 |
Release | 2012-07-05 |
Genre | Medical |
ISBN | 1139833049 |
This volume presents up-to-date, comprehensive and high quality reviews of the psychopharmacological evidence-base for each of the major psychiatric disorders, written by expert psychopharmacologists from around the world. Building on the success of the first edition, the volume summarizes the wealth of new developments in the field and sets them within the context of day-to-day clinical practice. All chapters have been fully updated and new contributions on personality disorders and substance dependence added. Each chapter provides information about optimal first line pharmacological interventions, maintenance pharmacotherapy and the management of treatment-refractory patients. The content is organized according to the DSM-V listing of psychiatric disorders, and covers all major conditions including schizophrenia, mood disorders, anxiety disorders, eating disorders and Alzheimer's disorder. These issues lie at the heart of clinical psychopharmacology, making this book invaluable to all practising and trainee clinicians, in a mental health setting or a less specialised environment.